Can Omalizumab Monotherapy Benefit Real-World Food Allergy Patients? Lessons From an Observational Study
J Allergy Clin Immunol Pract
.
2019 Jul-Aug;7(6):1910-1911.
doi: 10.1016/j.jaip.2019.05.007.
Author
Brian P Vickery
1
Affiliation
1
Emory University School of Medicine, Atlanta, Ga. Electronic address: bpvicke@emory.edu.
PMID:
31279468
DOI:
10.1016/j.jaip.2019.05.007
No abstract available
Publication types
Editorial
Comment
MeSH terms
Asthma*
Food Hypersensitivity*
Humans
Omalizumab
Substances
Omalizumab